764
Views
120
CrossRef citations to date
0
Altmetric
Original Article

Mucosal cytokine imbalance in irritable bowel syndrome

, , , , , , , , , & , FRCPI , MD , FRCP , FACP , FACG show all
Pages 1467-1476 | Received 16 Jun 2008, Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (13)

Marcello Fiorani, Livio Enrico Del Vecchio, Pasquale Dargenio, Francesco Kaitsas, Tommaso Rozera, Serena Porcari, Antonio Gasbarrini, Giovanni Cammarota & Gianluca Ianiro. (2023) Histamine-producing bacteria and their role in gastrointestinal disorders. Expert Review of Gastroenterology & Hepatology 17:7, pages 709-718.
Read now
Leif Kyrre Berg, Rasmus Goll, Erik Fagerli, Judith Krey Ludviksen, Hilde Fure, Odd Sverre Moen, Sveinung W. Sørbye, Tom Eirik Mollnes & Jon Florholmen. (2020) Intestinal inflammatory profile shows increase in a diversity of biomarkers in irritable bowel syndrome. Scandinavian Journal of Gastroenterology 55:5, pages 537-542.
Read now
Ellen Johanne Vara, Karl A Brokstad, Trygve Hausken & Gülen Arslan Lied. (2018) Altered levels of cytokines in patients with irritable bowel syndrome are not correlated with fatigue. International Journal of General Medicine 11, pages 285-291.
Read now
Simone Birgit Bayer, Richard Blair Gearry & Lynley Ngaio Drummond. (2018) Putative mechanisms of kiwifruit on maintenance of normal gastrointestinal function. Critical Reviews in Food Science and Nutrition 58:14, pages 2432-2452.
Read now
Athanasios Tsigaridas, Ioannis S. Papanikolaou, Anna Vaiopoulou, Athanasios K. Anagnostopoulos, Nikos Viazis, George Karamanolis, Dimitrios G. Karamanolis, George T. Tsangaris, Gerasimos J. Mantzaris & Maria Gazouli. (2017) Proteomics and irritable bowel syndrome. Expert Review of Proteomics 14:5, pages 461-468.
Read now
Magdy El-Salhy. (2015) Recent advances in the diagnosis of irritable bowel syndrome. Expert Review of Gastroenterology & Hepatology 9:9, pages 1161-1174.
Read now
Vladimir Stanisic & Eamonn MM Quigley. (2014) The overlap between IBS and IBD – what is it and what does it mean?. Expert Review of Gastroenterology & Hepatology 8:2, pages 139-145.
Read now
Beatriz Gras-Miralles & Efi Kokkotou. (2013) Immune biomarkers in irritable bowel syndrome: a review. Current Biomarker Findings 3, pages 43-53.
Read now
Patrycja Konieczna, Cezmi A. Akdis, Eamonn M.M. Quigley, Fergus Shanahan & Liam O'Mahony. (2012) Portrait of an immunoregulatory bifidobacterium. Gut Microbes 3:3, pages 261-266.
Read now
Andrey E Dorofeyev, Elena A Kiriyan, Inna V Vasilenko, Olga A Rassokhina & Andrey F Elin. (2011) Clinical, endoscopical and morphological efficacy of mesalazine in patients with irritable bowel syndrome. Clinical and Experimental Gastroenterology 4, pages 141-153.
Read now
Rolf Hultcrantz. (2008) This Month in Scandinavian Journal of Gastroenterology. Scandinavian Journal of Gastroenterology 43:12, pages 1411-1412.
Read now

Articles from other publishers (107)

Shih-Yao Chen, Chuan-Yin Fang, Bing-Hwa Su, Hao-Ming Chen, Shih-Chi Huang, Po-Ting Wu, Ai-Li Shiau & Chao-Liang Wu. (2024) Early Growth Response Protein 1 Exacerbates Murine Inflammatory Bowel Disease by Transcriptional Activation of Matrix Metalloproteinase 12. Biomedicines 12:4, pages 780.
Crossref
Youhe Wu, Shengjie Li, Longxian Lv, Shiman Jiang, Lvwan Xu, Hui Chen & Lanjuan Li. (2024) Protective effect of Pediococcus pentosaceus Li05 on diarrhea-predominant irritable bowel syndrome in rats . Food & Function 15:7, pages 3692-3708.
Crossref
Silvia Cruchet, Sandra Hirsch, Diana Villa-López, Mucio Moreno-Portillo, Juan C. Palomo, Ana T. Abreu-Abreu, Juan M. Abdo-Francis, Carlos Jiménez-Gutiérrez, Martin Rojano, Gabriel López-Velázquez & Pedro Gutiérrez-Castrellón. (2024) Limosilactobacillus reuteri DSM 17938 and ATCC PTA 6475 for the treatment of moderate to severe irritable bowel syndrome in adults: a randomized controlled trial. Frontiers in Gastroenterology 2.
Crossref
Li Cui, Shuting Zou, Jing Liu, Huixia Lv, Hui Li & Zhenhai Zhang. (2024) Potential effects of sodium hyaluronate on constipation-predominant irritable bowel syndrome. International Immunopharmacology 127, pages 111404.
Crossref
Suad M. SalmanHeba T. Yser. (2023) Evaluation of IL-8 and IL-10 Levels in men with Irritable Bowel Syndrome. Basrah Researches Sciences 49:1.
Crossref
Cristina Maria Sabo, Mohamed Ismaiel, Abdulrahman Ismaiel, Daniel-Corneliu Leucuta, Stefan-Lucian Popa, Simona Grad & Dan L. Dumitrascu. (2023) Do Colonic Mucosal Tumor Necrosis Factor Alpha Levels Play a Role in Diverticular Disease? A Systematic Review and Meta-Analysis. International Journal of Molecular Sciences 24:12, pages 9934.
Crossref
Sholpan Omarova, Karem Awad, Verena Moos, Christoph Püning, Greta Gölz, Jörg-Dieter Schulzke & Roland Bücker. (2023) Intestinal Barrier in Post-Campylobacter jejuni Irritable Bowel Syndrome. Biomolecules 13:3, pages 449.
Crossref
Karem Awad, Christian Barmeyer, Christian Bojarski, Oliver Nagel, In-Fah M. Lee, Michal R. Schweiger, Jörg-Dieter Schulzke & Roland Bücker. (2023) Impaired Intestinal Permeability of Tricellular Tight Junctions in Patients with Irritable Bowel Syndrome with Mixed Bowel Habits (IBS-M). Cells 12:2, pages 236.
Crossref
Sylwia Smolinska, Ewa Winiarska, Anna Globinska & Marek Jutel. (2022) Histamine: A Mediator of Intestinal Disorders—A Review. Metabolites 12:10, pages 895.
Crossref
Michael Camilleri, Yorick Magnus, Paula Carlson, Xiao Jing Wang, Victor Chedid, Daniel Maselli, Ann Taylor, Sanna McKinzie, Nagaswaroop Kengunte Nagaraj, Irene Busciglio & Asha Nair. (2022) Differential mRNA expression in ileal and colonic biopsies in irritable bowel syndrome with diarrhea or constipation. American Journal of Physiology-Gastrointestinal and Liver Physiology 323:2, pages G88-G101.
Crossref
Sunil Kumar, Priyanka Singh & Awanish Kumar. (2021) Targeted therapy of irritable bowel syndrome with anti-inflammatory cytokines. Clinical Journal of Gastroenterology 15:1, pages 1-10.
Crossref
Tatiani Uceli Maioli, Luísa Martins Trindade, Aline Souza, Lícia Torres, Maria Emília Rabelo Andrade, Valbert Nascimento Cardoso & Simone Vasconcelos Generoso. (2022) Non-pharmacologic strategies for the management of intestinal inflammation. Biomedicine & Pharmacotherapy 145, pages 112414.
Crossref
Seonhye Yu, Eunho Chun, Yeounjung Ji, Young Joo Lee & Mirim Jin. (2021) Effects of red ginseng on gut, microbiota, and brain in a mouse model of post-infectious irritable bowel syndrome. Journal of Ginseng Research 45:6, pages 706-716.
Crossref
Elizabeth J. Videlock & Lin Chang. (2021) Latest Insights on the Pathogenesis of Irritable Bowel Syndrome. Gastroenterology Clinics of North America 50:3, pages 505-522.
Crossref
Xiaodan Shi, Yedong Hu, Bo Zhang, Wenna Li, Jiande DZ Chen & Fei Liu. (2021) Ameliorating effects and mechanisms of transcutaneous auricular vagal nerve stimulation on abdominal pain and constipation. JCI Insight 6:14.
Crossref
Guanhua Rao & Zhijian Meng. (2021) A commentary on “The efficacy and safety of probiotics for patients with constipation predominant irritable bowel syndrome: A systematic review and meta-analysis based on seventeen randomized controlled trials” [Int. J. Surg. 2020; 79: 111–119]. International Journal of Surgery 91, pages 105993.
Crossref
V. Ivashkin, Y. Poluektov, E. Kogan, O. Shifrin, A. Sheptulin, A. Kovaleva, A. Kurbatova, G. Krasnov & E. Poluektova. (2021) Disruption of the pro-inflammatory, anti-inflammatory cytokines and tight junction proteins expression, associated with changes of the composition of the gut microbiota in patients with irritable bowel syndrome. PLOS ONE 16:6, pages e0252930.
Crossref
Andres Gottfried-BlackmoreHong NamkoongEmerald AdlerBrock MartinJohn GubatanNielsen Fernandez-BeckerJohn O. ClarkeJuliana IdoyagaLinda NguyenAida Habtezion. (2021) Gastric Mucosal Immune Profiling and Dysregulation in Idiopathic Gastroparesis. Clinical and Translational Gastroenterology 12:5, pages e00349.
Crossref
Chenyu LiYujun ShuaiXiaodong Zhou & Hongxia Chen. (2020) Association between Helicobacter pylori infection and irritable bowel syndrome. Medicine 99:50, pages e22975.
Crossref
Giuseppe Losurdo, Alessia Todeschini, Floriana Giorgio, Domenico Piscitelli, Antonio Giangaspero, Enzo Ierardi & Alfredo Di Leo. (2020) Human Leukocyte Antigen (HLA) Haplotype Does Not Influence the Inflammatory Pattern of Duodenal Lymphocytosis Linked to Irritable Bowel Syndrome. Medicina 56:12, pages 660.
Crossref
Caterina Carco, Wayne Young, Richard B. Gearry, Nicholas J. Talley, Warren C. McNabb & Nicole C. Roy. (2020) Increasing Evidence That Irritable Bowel Syndrome and Functional Gastrointestinal Disorders Have a Microbial Pathogenesis. Frontiers in Cellular and Infection Microbiology 10.
Crossref
Yong Wen, Jun Li, Qing Long, Chao-chi Yue, Bing He & Xue-gui Tang. (2020) The efficacy and safety of probiotics for patients with constipation-predominant irritable bowel syndrome: A systematic review and meta-analysis based on seventeen randomized controlled trials. International Journal of Surgery 79, pages 111-119.
Crossref
Lienda Bashier El, Doa Shams, Nazik Babikr, Mohammed Madani, Sara Abdelghani & Hisham Ali Waggia. (2020) Serum Levels of Interferon Gamma INF-γ and Interleukin 10 Il-10: an Immunological Aspect among Irritable Bowel Syndrome Patients. Pakistan Journal of Biological Sciences 23:7, pages 898-903.
Crossref
Kewin T H Siah, Amelia Santosa, Cynthia K Y Cheung, Alex Y S Soh & Paul L Bigliardi. (2020) Atopic Patients Who Fulfilled Rome III Criteria for Irritable Bowel Syndrome Had Higher Animal Danders Sensitization. Journal of Neurogastroenterology and Motility 26:2, pages 267-273.
Crossref
Heng-Li Niu & Ji-Yuan Xiao. (2020) The efficacy and safety of probiotics in patients with irritable bowel syndrome: Evidence based on 35 randomized controlled trials. International Journal of Surgery 75, pages 116-127.
Crossref
Rebecca O’Brien & Dervla O’Malley. (2019) The Glucagon‐like peptide‐1 receptor agonist, exendin‐4, ameliorated gastrointestinal dysfunction in the Wistar Kyoto rat model of Irritable Bowel Syndrome. Neurogastroenterology & Motility 32:2.
Crossref
Ju Yup Lee, Nayoung Kim, Ji Hyun Park, Ryoung Hee Nam, Sun Min Lee, Chin-Hee Song, Geun Kim, Hee Young Na, Yoon Jin Choi, Jin Joo Kim & Dong Ho Lee. (2020) Expression of Neurotrophic Factors, Tight Junction Proteins, and Cytokines According to the Irritable Bowel Syndrome Subtype and Sex. Journal of Neurogastroenterology and Motility 26:1, pages 106-116.
Crossref
Adrian Szczepaniak & Marta Zielińska. 2020. A Comprehensive Overview of Irritable Bowel Syndrome. A Comprehensive Overview of Irritable Bowel Syndrome 43 56 .
Zhi-Chao Yu, Yong-Xin Cen, Ben-Hua Wu, Cheng Wei, Feng Xiong, De-Feng Li, Ting-Ting Liu, Ming-Han Luo, Li-Liangzi Guo, Ying-Xue Li, Li-Sheng Wang, Jian-Yao Wang & Jun Yao. (2019) Berberine prevents stress-induced gut inflammation and visceral hypersensitivity and reduces intestinal motility in rats. World Journal of Gastroenterology 25:29, pages 3956-3971.
Crossref
Javier Aguilera‐Lizarraga, Morgane V. Florens, Thomas Van Brussel, Egbert Clevers, Lukas Van Oudenhove, Diether Lambrechts, Mira M. Wouters & Guy E. Boeckxstaens. (2019) Expression of immune‐related genes in rectum and colon descendens of Irritable Bowel Syndrome patients is unrelated to clinical symptoms . Neurogastroenterology & Motility 31:6.
Crossref
Prianka Gajula & Eamonn M. Quigley. (2019) Overlapping irritable bowel syndrome and inflammatory bowel disease. Minerva Gastroenterologica e Dietologica 65:2.
Crossref
Grace BurnsGeorgia CarrollAndrea MatheJay HorvatPaul FosterMarjorie M. WalkerNicholas J. TalleySimon Keely. (2018) Evidence for Local and Systemic Immune Activation in Functional Dyspepsia and the Irritable Bowel Syndrome: A Systematic Review. American Journal of Gastroenterology 114:3, pages 429-436.
Crossref
N. L. Lilli, L. Quénéhervé, S. Haddara, C. Brochard, P. Aubert, M. Rolli‐Derkinderen, T. Durand, P. Naveilhan, J.‐B. Hardouin, R. De Giorgio, G. Barbara, S. Bruley des Varannes, E. Coron & M. Neunlist. (2017) Glioplasticity in irritable bowel syndrome. Neurogastroenterology & Motility 30:4.
Crossref
Bruno K. Rodiño-Janeiro, Cristina Martínez, Marina Fortea, Beatriz Lobo, Marc Pigrau, Adoración Nieto, Ana María González-Castro, Eloísa Salvo-Romero, Danila Guagnozzi, Cristina Pardo-Camacho, Cristina Iribarren, Fernando Azpiroz, Carmen Alonso-Cotoner, Javier Santos & Maria Vicario. (2018) Decreased TESK1-mediated cofilin 1 phosphorylation in the jejunum of IBS-D patients may explain increased female predisposition to epithelial dysfunction. Scientific Reports 8:1.
Crossref
G. E. Boeckxstaens & M. M. Wouters. (2016) Neuroimmune factors in functional gastrointestinal disorders: A focus on irritable bowel syndrome. Neurogastroenterology & Motility 29:6.
Crossref
Nick Powell, Marjorie M. Walker & Nicholas J. Talley. (2017) The mucosal immune system: master regulator of bidirectional gut–brain communications. Nature Reviews Gastroenterology & Hepatology 14:3, pages 143-159.
Crossref
Sunil Kumar, Ratnakar Shukla, Prabhat Ranjan & Awanish Kumar. (2017) Interleukin-10: A Compelling Therapeutic Target in Patients With Irritable Bowel Syndrome. Clinical Therapeutics 39:3, pages 632-643.
Crossref
Melissa A. Campaniello, Chris Mavrangelos, Samuel Eade, Andrea M. Harrington, L. Ashley Blackshaw, Stuart M. Brierley, Scott D. Smid & Patrick A. Hughes. (2017) Acute colitis chronically alters immune infiltration mechanisms and sensory neuro-immune interactions. Brain, Behavior, and Immunity 60, pages 319-332.
Crossref
Hyo Jeong Lee, Jong Kyoung Choi, Han Seung Ryu, Chang Hwan Choi, Eun Hee Kang, Kyung Sik Park, Yang Won Min & Kyoung Sup Hong. (2017) Therapeutic Modulation of Gut Microbiota in Functional Bowel Disorders. Journal of Neurogastroenterology and Motility 23:1, pages 9-19.
Crossref
Seyedmehdi Seyedmirzaee, Mohammad Mahdi Hayatbakhsh, Bizhan Ahmadi, Nadieh Baniasadi, Afshin Mohammad Bagheri Rafsanjani, Amin Reza Nikpoor & Mojgan Mohammadi. (2016) Serum immune biomarkers in irritable bowel syndrome. Clinics and Research in Hepatology and Gastroenterology 40:5, pages 631-637.
Crossref
Juan J Martin‐Viñas & Eamonn M M Quigley. (2016) Immune response in irritable bowel syndrome: A systematic review of systemic and mucosal inflammatory mediators. Journal of Digestive Diseases 17:9, pages 572-581.
Crossref
Sean M P Bennet, Annikka Polster, Hans Törnblom, Stefan Isaksson, Sandrine Capronnier, Aurore Tessier, Boris Le Nevé, Magnus Simrén & Lena Öhman. (2016) Global Cytokine Profiles and Association With Clinical Characteristics in Patients With Irritable Bowel Syndrome. American Journal of Gastroenterology 111:8, pages 1165-1176.
Crossref
Li Li, Lishou Xiong, Junhua Yao, Xiaojun Zhuang, Shenghong Zhang, Qiao Yu, Yinglian Xiao, Yi Cui & Minhu Chen. (2016) Increased small intestinal permeability and RNA expression profiles of mucosa from terminal ileum in patients with diarrhoea-predominant irritable bowel syndrome. Digestive and Liver Disease 48:8, pages 880-887.
Crossref
Maria Raffaella BarbaroAntonio Di SabatinoCesare CremonPaolo GiuffridaMichelangelo Fiorentino, Annalisa Altimari, Lara BellacosaVincenzo StanghelliniGiovanni Barbara. (2016) Interferon-γ is increased in the gut of patients with irritable bowel syndrome and modulates serotonin metabolism. American Journal of Physiology-Gastrointestinal and Liver Physiology 310:6, pages G439-G447.
Crossref
Eamonn M. M. Quigley. (2015) Overlapping irritable bowel syndrome and inflammatory bowel disease: less to this than meets the eye?. Therapeutic Advances in Gastroenterology 9:2, pages 199-212.
Crossref
Erdem Koçak, Erdem Akbal, Seyfettin Köklü, Bilal Ergül & Murat Can. (2016) The Colonic Tissue Levels of TLR2, TLR4 and Nitric Oxide in Patients with Irritable Bowel Syndrome. Internal Medicine 55:9, pages 1043-1048.
Crossref
Hua Chu, Mark Fox, Xia Zheng, Yanyong Deng, Yanqin Long, Zhihui Huang, Lijun Du, Fei Xu & Ning Dai. (2016) Small Intestinal Bacterial Overgrowth in Patients with Irritable Bowel Syndrome: Clinical Characteristics, Psychological Factors, and Peripheral Cytokines. Gastroenterology Research and Practice 2016, pages 1-8.
Crossref
James S. Pearson, Robert M. Niven, Jie Meng, Sima Atarodi & Peter J. Whorwell. (2015) Immunoglobulin E in irritable bowel syndrome: another target for treatment? A case report and literature review. Therapeutic Advances in Gastroenterology 8:5, pages 270-277.
Crossref
Parth J Parekh, Luis A Balart & David A Johnson. (2015) The Influence of the Gut Microbiome on Obesity, Metabolic Syndrome and Gastrointestinal Disease. Clinical and Translational Gastroenterology 6:6, pages e91.
Crossref
Sean M.P. Bennet, Lena Ohman & Magnus Simren. (2015) Gut Microbiota as Potential Orchestrators of Irritable Bowel Syndrome. Gut and Liver 9:3.
Crossref
Juan José Sebastián Domingo & Beatriz Sebastián Sánchez. (2015) Psiconeuroinmunología en el síndrome del intestino irritable. Gastroenterología y Hepatología.
Crossref
Dervla O’Malley, Maria M. Buckley, Declan P. McKernan, Eamonn M.M. Quigley, John F. Cryan & Timothy G. Dinan. (2015) Soluble mediators in plasma from irritable bowel syndrome patients excite rat submucosal neurons. Brain, Behavior, and Immunity 44, pages 57-67.
Crossref
Magdy El-Salhy. (2015) Recent developments in the pathophysiology of irritable bowel syndrome. World Journal of Gastroenterology 21:25, pages 7621.
Crossref
Leonard B. Weinstock & Arthur S. Walters. 2015. Modulation of Sleep by Obesity, Diabetes, Age, and Diet. Modulation of Sleep by Obesity, Diabetes, Age, and Diet 235 242 .
Patrick A. Hughes, Melissa Moretta, Amanda Lim, Dallas J. Grasby, Daniel Bird, Stuart M. Brierley, Tobias Liebregts, Birgit Adam, L. Ashley Blackshaw, Gerald Holtmann, Peter Bampton, Peter Hoffmann, Jane M. Andrews, Heddy Zola & Doreen Krumbiegel. (2014) Immune derived opioidergic inhibition of viscerosensory afferents is decreased in Irritable Bowel Syndrome patients. Brain, Behavior, and Immunity 42, pages 191-203.
Crossref
Alexander C Ford, Eamonn M M Quigley, Brian E Lacy, Anthony J Lembo, Yuri A Saito, Lawrence R Schiller, Edy E Soffer, Brennan M R Spiegel & Paul Moayyedi. (2014) Efficacy of Prebiotics, Probiotics, and Synbiotics in Irritable Bowel Syndrome and Chronic Idiopathic Constipation: Systematic Review and Meta-analysis. American Journal of Gastroenterology 109:10, pages 1547-1561.
Crossref
Stephen M. Collins. (2014) A role for the gut microbiota in IBS. Nature Reviews Gastroenterology & Hepatology 11:8, pages 497-505.
Crossref
M. Bashashati, N. Rezaei, A. Shafieyoun, D. P. McKernan, L. Chang, L. Öhman, E. M. Quigley, M. Schmulson, K. A. Sharkey & M. Simrén. (2014) Cytokine imbalance in irritable bowel syndrome: a systematic review and meta‐analysis. Neurogastroenterology & Motility 26:7, pages 1036-1048.
Crossref
Aoife O'Donovan. (2014) Inflammation and Depression. Journal of Pediatric Gastroenterology and Nutrition 58:5, pages 541-542.
Crossref
S. Smolinska, M. Jutel, R. Crameri & L. O'Mahony. (2014) Histamine and gut mucosal immune regulation. Allergy 69:3, pages 273-281.
Crossref
I.W. FongI. W. Fong. 2014. The Role of Microbes in Common Non-Infectious Diseases. The Role of Microbes in Common Non-Infectious Diseases 1 27 .
Yehuda Ringel & Nitsan Maharshak. (2013) Intestinal microbiota and immune function in the pathogenesis of irritable bowel syndrome. American Journal of Physiology-Gastrointestinal and Liver Physiology 305:8, pages G529-G541.
Crossref
Eamonn MM Quigley. (2013) Editorial: PARs for the Course: Roles of Proteases and PAR Receptors in Subtly Inflamed Irritable Bowel Syndrome. American Journal of Gastroenterology 108:10, pages 1644-1646.
Crossref
Man-Chin Hua, Hsun-Chin Chao, Tsung-Chieh Yao, Ming-Wei Lai, Jing-Long Huang & the PATCH Study Group. (2013) Investigation of Interleukin-10 Promoter Polymorphisms and Interleukin-10 Levels in Children with Irritable Bowel Syndrome. Gut and Liver 7:4, pages 430-436.
Crossref
Patrick A Hughes, Heddy Zola, Irmeli A Penttila, Ashley L Blackshaw, Jane M Andrews & Doreen Krumbiegel. (2013) Immune Activation in Irritable Bowel Syndrome: Can Neuroimmune Interactions Explain Symptoms?. American Journal of Gastroenterology 108:7, pages 1066-1074.
Crossref
Kok‐Ann Gwee. 2013. Irritable Bowel Syndrome. Irritable Bowel Syndrome 159 181 .
Dervla O’Malley, John F. Cryan & Timothy G. Dinan. (2013) Crosstalk between interleukin-6 and corticotropin-releasing factor modulate submucosal plexus activity and colonic secretion. Brain, Behavior, and Immunity 30, pages 115-124.
Crossref
Shunji Ishihara, Yasumasa Tada, Nobuhiko Fukuba, Akihiko Oka, Ryusaku Kusunoki, Yoshiyuki Mishima, Naoki Oshima, Ichiro Moriyama, Takafumi Yuki, Kousaku Kawashima & Yoshikazu Kinoshita. (2013) Pathogenesis of Irritable Bowel Syndrome - Review Regarding Associated Infection and Immune Activation. Digestion 87:3, pages 204-211.
Crossref
Chad K Porter, Brooks D Cash, Mark Pimentel, Akintunde Akinseye & Mark S Riddle. (2012) Risk of inflammatory bowel disease following a diagnosis of irritable bowel syndrome. BMC Gastroenterology 12:1.
Crossref
Jill M. Hoffman. (2012) Irritable bowel syndrome: is the colonic mucosa to blame?. Neurogastroenterology & Motility 24:12, pages 1051-1053.
Crossref
S. Buhner, Q. Li, T. Berger, S. Vignali, G. Barbara, R. De Giorgio, V. Stanghellini & M. Schemann. (2012) Submucous rather than myenteric neurons are activated by mucosal biopsy supernatants from irritable bowel syndrome patients. Neurogastroenterology & Motility 24:12, pages 1134.
Crossref
M. Bashashati, N. Rezaei, H. Bashashati, A. Shafieyoun, N. E. Daryani, K. A. Sharkey & M. Storr. (2012) Cytokine gene polymorphisms are associated with irritable bowel syndrome: a systematic review and meta‐analysis. Neurogastroenterology & Motility 24:12, pages 1102.
Crossref
J. Matricon, M. Meleine, A. Gelot, T. Piche, M. Dapoigny, E. Muller & D. Ardid. (2012) Review article: associations between immune activation, intestinal permeability and the irritable bowel syndrome. Alimentary Pharmacology & Therapeutics 36:11-12, pages 1009-1031.
Crossref
Giovanni Barbara, Lisa Zecchi, Raffaella Barbaro, Cesare Cremon, Lara Bellacosa, Marco Marcellini, Roberto De Giorgio, Roberto Corinaldesi & Vincenzo Stanghellini. (2012) Mucosal Permeability and Immune Activation as Potential Therapeutic Targets of Probiotics in Irritable Bowel Syndrome. Journal of Clinical Gastroenterology 46, pages S52-S55.
Crossref
Mirza Romero-Valdovinos, Areli Gudiño-Ramírez, Jesús Reyes-Gordillo, Williams Arony Martínez-Flores, María Elena Ramírez-Miranda, Pablo Maravilla & Angélica Olivo-Díaz. (2012) Interleukin-8 and -10 gene polymorphisms in irritable bowel syndrome. Molecular Biology Reports 39:9, pages 8837-8843.
Crossref
Ali S. Khashan, Eamonn M.M. Quigley, Roseanne McNamee, Fergus P. McCarthy, Fergus Shanahan & Louise C. Kenny. (2012) Increased Risk of Miscarriage and Ectopic Pregnancy Among Women With Irritable Bowel Syndrome. Clinical Gastroenterology and Hepatology 10:8, pages 902-909.
Crossref
Goran Hauser, Mladenka Tkalcic, Sanda Pletikosic, Nina Grabar & Davor Stimac. (2012) Erythrocyte sedimentation rate – Possible role in determining the existence of the low grade inflammation in Irritable Bowel Syndrome patients. Medical Hypotheses 78:6, pages 818-820.
Crossref
Bin Feng, Jun Ho La, Erica S. Schwartz & G. F. Gebhart. (2012) Irritable Bowel Syndrome: Methods, Mechanisms, and Pathophysiology. Neural and neuro-immune mechanisms of visceral hypersensitivity in irritable bowel syndrome. American Journal of Physiology-Gastrointestinal and Liver Physiology 302:10, pages G1085-G1098.
Crossref
A. Tursi, W. Elisei, G. Brandimarte, G. M. Giorgetti, C. D. Inchingolo, R. Nenna, M. Picchio, F. Giorgio & E. Ierardi. (2012) Musosal tumour necrosis factor α in diverticular disease of the colon is overexpressed with disease severity. Colorectal Disease 14:5.
Crossref
Breg Braak, Tamira K Klooker, Mira M Wouters, Olaf Welting, Chris M van der Loos, Oana I Stanisor, Sophie van Diest, Rene M van den Wijngaard & Guy E Boeckxstaens. (2012) Mucosal Immune Cell Numbers and Visceral Sensitivity in Patients With Irritable Bowel Syndrome: Is There Any Relationship?. American Journal of Gastroenterology 107:5, pages 715-726.
Crossref
Max Schmulson, Daniela Pulido-London, Oscar Rodriguez, Norma Morales-Rochlin, Rosalinda Martinez-García, Ma Concepción Gutierrez-Ruiz, Juan Carlos López-Alvarenga, Guillermo Robles-Díaz & Gabriela Gutiérrez-Reyes. (2012) Lower Serum IL-10 Is an Independent Predictor of IBS Among Volunteers in Mexico. American Journal of Gastroenterology 107:5, pages 747-753.
Crossref
Cristina Martínez, María Vicario, Laura Ramos, Beatriz Lobo, Jose Luis Mosquera, Carmen Alonso, Alex Sánchez, Mar Guilarte, María Antolín, Inés de Torres, Ana M González-Castro, Marc Pigrau, Esteban Saperas, Fernando Azpiroz & Javier Santos. (2012) The Jejunum of Diarrhea-Predominant Irritable Bowel Syndrome Shows Molecular Alterations in the Tight Junction Signaling Pathway That Are Associated With Mucosal Pathobiology and Clinical Manifestations. American Journal of Gastroenterology 107:5, pages 736-746.
Crossref
Max Schmulson & William D Chey. (2012) Editorial: Abnormal Immune Regulation and Low-Grade Inflammation in IBS: Does One Size Fit All?. American Journal of Gastroenterology 107:2, pages 273-275.
Crossref
Lin Chang, Mopelola Adeyemo, Iordanis Karagiannidis, Elizabeth J Videlock, Collin Bowe, Wendy Shih, Angela P Presson, Pu-Qing Yuan, Galen Cortina, Hua Gong, Sharat Singh, Arlene Licudine, Minou Mayer, Yvette Tache, Charalabos Pothoulakis & Emeran A Mayer. (2012) Serum and Colonic Mucosal Immune Markers in Irritable Bowel Syndrome. American Journal of Gastroenterology 107:2, pages 262-272.
Crossref
Mohammad Bashashati, Nima Rezaei, Christopher N. Andrews, Chun-Qiu Chen, Nasser Ebrahimi Daryani, Keith A. Sharkey & Martin A. Storr. (2012) Cytokines and irritable bowel syndrome: Where do we stand?. Cytokine 57:2, pages 201-209.
Crossref
Zhonghan Yang, Viktoriya Grinchuk, Siu Po Ip, Chun-Tao Che, Harry H. S. Fong, Lixing Lao, Justin C. Wu, Joseph J. Sung, Brian Berman, Terez Shea-Donohue & Aiping Zhao. (2012) Anti-Inflammatory Activities of a Chinese Herbal Formula IBS-20 In Vitro and In Vivo . Evidence-Based Complementary and Alternative Medicine 2012, pages 1-12.
Crossref
Sabine Buhner & Michael Schemann. (2012) Mast cell–nerve axis with a focus on the human gut. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1822:1, pages 85-92.
Crossref
Trevor Huyton, Wiebke Göttmann, Christina Bade-Döding, Ananta Paine & Rainer Blasczyk. (2011) The T/NK cell co-stimulatory molecule SECTM1 is an IFN “early response gene” that is negatively regulated by LPS in Human monocytic cells. Biochimica et Biophysica Acta (BBA) - General Subjects 1810:12, pages 1294-1301.
Crossref
M. Bortolotti & S. Porta. (2011) Effect of Red Pepper on Symptoms of Irritable Bowel Syndrome: Preliminary Study. Digestive Diseases and Sciences 56:11, pages 3288-3295.
Crossref
Giovanni Barbara, Cesare Cremon, Giovanni Carini, Lara Bellacosa, Lisa Zecchi, Roberto De Giorgio, Roberto Corinaldesi & Vincenzo Stanghellini. (2011) The Immune System in Irritable Bowel Syndrome. Journal of Neurogastroenterology and Motility 17:4, pages 349-359.
Crossref
Dervla O’Malley, Eamonn M.M. Quigley, Timothy G. Dinan & John F. Cryan. (2011) Do interactions between stress and immune responses lead to symptom exacerbations in irritable bowel syndrome?. Brain, Behavior, and Immunity 25:7, pages 1333-1341.
Crossref
Giovanni Barbara, Cesare Cremon, Roberto De Giorgio, Giovanni Dothel, Lisa Zecchi, Lara Bellacosa, Giovanni Carini, Vincenzo Stanghellini & Roberto Corinaldesi. (2011) Mechanisms Underlying Visceral Hypersensitivity in Irritable Bowel Syndrome. Current Gastroenterology Reports 13:4, pages 308-315.
Crossref
Ru Zhang, Ning Zou, Ji Li, Hong Lv, Jing Wei, Xiu-Cai Fang & Jia-Ming Qian. (2011) Elevated expression of c-fos in central nervous system correlates with visceral hypersensitivity in irritable bowel syndrome (IBS): a new target for IBS treatment. International Journal of Colorectal Disease 26:8, pages 1035-1044.
Crossref
Dervla O'Malley, Timothy G. Dinan & John F. Cryan. (2011) Altered expression and secretion of colonic Interleukin-6 in a stress-sensitive animal model of brain-gut axis dysfunction. Journal of Neuroimmunology 235:1-2, pages 48-55.
Crossref
Alexander C. Ford & Nicholas J. Talley. (2011) Mucosal inflammation as a potential etiological factor in irritable bowel syndrome: a systematic review. Journal of Gastroenterology 46:4, pages 421-431.
Crossref
Eamonn M.M. Quigley. (2011) Therapies Aimed at the Gut Microbiota and Inflammation: Antibiotics, Prebiotics, Probiotics, Synbiotics, Anti-inflammatory Therapies. Gastroenterology Clinics of North America 40:1, pages 207-222.
Crossref
Dervla O'MalleyMartin ListonNiall P. HylandTimothy G. Dinan & John F. Cryan. (2011) Colonic soluble mediators from the maternal separation model of irritable bowel syndrome activate submucosal neurons via an interleukin-6-dependent mechanism. American Journal of Physiology-Gastrointestinal and Liver Physiology 300:2, pages G241-G252.
Crossref
Giovanni Barbara. (2011) Toll-Like Receptor Expression in Irritable Bowel Syndrome: On the Alert for a Microbial Threat?. American Journal of Gastroenterology 106:2, pages 337-339.
Crossref
Elizabeth K Brint, John MacSharry, Aine Fanning, Fergus Shanahan & Eamonn M M Quigley. (2011) Differential Expression of Toll-Like Receptors in Patients With Irritable Bowel Syndrome. American Journal of Gastroenterology 106:2, pages 329-336.
Crossref
Anne Salonen, Willem M. de Vos & Airi Palva. (2010) Gastrointestinal microbiota in irritable bowel syndrome: present state and perspectives. Microbiology 156:11, pages 3205-3215.
Crossref
Oscar Rodríguez-Fandiño, Joselín Hernández-Ruiz & Max Schmulson. (2010) From Cytokines to Toll-Like Receptors and Beyond - Current Knowledge and Future Research Needs in Irritable Bowel Syndrome. Journal of Neurogastroenterology and Motility 16:4, pages 363-373.
Crossref
Elizabeth C. Verna & Susan Lucak. (2010) Use of probiotics in gastrointestinal disorders: what to recommend?. Therapeutic Advances in Gastroenterology 3:5, pages 307-319.
Crossref
Millie D Long & Douglas A Drossman. (2010) Inflammatory Bowel Disease, Irritable Bowel Syndrome, or What?: A Challenge to the Functional–Organic Dichotomy. American Journal of Gastroenterology 105:8, pages 1796-1798.
Crossref
Gerard Clarke, Peter Fitzgerald, Alan A. Hennessy, Eugene M. Cassidy, Eamonn M.M. Quigley, Paul Ross, Catherine Stanton, John F. Cryan & Timothy G. Dinan. (2010) Marked elevations in pro-inflammatory polyunsaturated fatty acid metabolites in females with irritable bowel syndrome. Journal of Lipid Research 51:5, pages 1186-1192.
Crossref
Lena Öhman & Magnus Simrén. (2010) Pathogenesis of IBS: role of inflammation, immunity and neuroimmune interactions. Nature Reviews Gastroenterology & Hepatology 7:3, pages 163-173.
Crossref
Sabine Buhner, Qin Li, Sheila Vignali, Giovanni Barbara, Roberto De Giorgio, Vincenzo Stanghellini, Cesare Cremon, Florian Zeller, Rupert Langer, Hannelore Daniel, Klaus Michel & Michael Schemann. (2009) Activation of Human Enteric Neurons by Supernatants of Colonic Biopsy Specimens From Patients With Irritable Bowel Syndrome. Gastroenterology 137:4, pages 1425-1434.
Crossref
Eamonn M. M. Quigley. (2009) Probiotics and Irritable Bowel Syndrome. Bioscience and Microflora 28:4, pages 119-124.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.